ETA (Eicosatetraenoic Acid): The Omega-3 Your Joint Supplement Is Missing

If you've ever wondered why green lipped mussel oil is considered different from standard fish oil, ETA is a big part of the answer. Eicosatetraenoic acid (ETA) is an omega-3 fatty acid found almost exclusively in New Zealand green lipped mussel oil — not in salmon, cod, or krill. Research into its role in supporting a healthy inflammatory response is ongoing and promising. Here's what we know.*

If you follow medical news or are a regular customer of omega-3 supplements, you may have heard about an omega that is quickly rising in popularity for its rapid work in reducing joint pain and inflammation. This 'mega-omega' is called ETA, and here's everything you need to know about it.

First things first. What is ETA?

ETA stands for eicosatetraenoic acid. Eicosatetraenoic acid designates any straight chain 20:4 fatty acid. This sounds quite technical, we know, but is important because it signifies the omega's efficiency. It is found in green-lipped mussel oil such as that used in GLX3. To bring even more science talk to the table, ETA acts as a dual inhibitor of arachidonic acid oxygenation by both lipoxygenase and the cyclooxygenase (COX) pathway. It is a long-chain omega-3 molecule that can be converted into 2 novel compounds associated with inflammation management.

Like other omega-3s, ETA is not only anti-inflammatory, but it can also restrict your body's release of one of the root causes of your pain — the inflammatory omega-6 fatty acid known as arachidonic acid (ARA). In fact, ETA redirects the enzyme that normally creates ARA to convert it to EPA instead, in a sort of full-circle cycle of anti-inflammatory awesomeness.

How does ETA help to reduce joint pain and inflammation?

ETA content is usually not fully identified in human tissue. The reason for this is its low abundance. But with the emerging (SDA)- comprising of dietary oils like Buglossoides oil and Echium, measurable quantities of ETA in human erythrocytes, leukocytes and plasma are estimated after as little as two to four weeks of dietary supplementation (with a product such as GLX3) as a result of SDA elongation. So, if you started taking GLX3 today, you could be reaping the benefit of increased ETA as soon as next month. If you're weighing your options, it's also worth understanding mussel oil vs. freeze-dried powder — the form of green-lipped mussel you take can impact how well ETA is absorbed and preserved.

Hence, natural LTB4 (Leukotriene B4 is a leukotriene involved in inflammation) receptor antagonists like ∆17-8, 15–diHETE (diHETE is a double oxidation product of arachidonic acid) may be produced at inflammatory sites when stearidonic acid is used as supplementation in the diet and could benefit people with inflammatory diseases.

ETA possess pro-solving or anti-inflammatory activities analogous to the well-described EPA (eicosapentaenoic acid), DPA (Docosapentaenoic acid) and DHA (docosahexaenoic acid) – derived resolvins, protectins, and maresins. These resolvins, protectins and maresins products of dual lipoxygenase activities and it is also reported that ETA (Eicosatetraenoic acid) is also a substrate for the generation of such metabolites.

ETA (Eicosatetraenoic acid) – a new kid on the block of omega chain

ETA (Eicosatetraenoic acid) and its precursor SDA (Stearidonic acid). These Omega-3 fatty acids are rare in nature. Both of these omega-3s fatty acids have some degree of "pathway inhibitory action" causing blockage of short-term pain and inflammation in the prostanoids (from COX -2) and the long-term immune attacks that are the alarming signs of the leukotrienes (from LOX).

These actions are based on several features of the body processing of fatty acids, actions of enzymes and their impacts on a group of local and cellular hormones know as eicosanoids COX -2 inhibitors help in accelerating the inflammation in the long-term by diversion of arachidonic acid into another, slow acting and ultimately more destruction causing pathway; the lipoxygenase (LOX) pathway, that releases the ravaging series-4 leukotrienes.

Research has shown that ETA is found exclusively in the Green-Lipped Mussel blocks both the COX-2 and LOX inflammatory pathways simultaneously and minimizes inflammation more effectively in comparison to other Omega-3s and NSAID's without causing harm to guts and kidneys. When comparing green lipped mussel oil vs. fish oil, this dual-pathway blocking ability is exactly what sets mussel oil apart — standard fish oil simply cannot replicate it. Mussels serve as a controlling mechanism for leukotriene – amino acid involved in the regulation of immune responses like the histamine and in inflammation.

ETA exclusively found in New Zealand's Green Lipped Mussels offers unique anti-inflammatory benefits to the COX and LOX pathways, which you'll feel by way of reduced joint pain and inflammation. One of the biggest disadvantages of non-steroidal anti-inflammatory drugs and other COX pathway blockers is that they inhibit the COX 1 pathway that is responsible for maintaining moisture levels in the body's mucus membranes (both the colon and sinuses). You actually need this mucus to stay healthy, and ETA can help ensure you are getting it. If you aren't, this can result in symptoms like constipation, frequent nosebleeds, and even dehydration.
ETA and lipids in Green Lipped Mussels do not inhibit the COX 1 pathway, and hence they help in reducing inflammation and pain without any painful side effects that are caused by other sources of Omega-3 sources. If you're ready to experience these benefits for yourself, learning how much to take is a great next step to getting started the right way.

FAQ: ETA Omega-3 and Joint Health

Q: What is an ETA supplement?

ETA (eicosatetraenoic acid) isn't sold as a standalone supplement — it's naturally concentrated in New Zealand green-lipped mussel oil. If you're looking for an ETA supplement, you're looking for a high-quality mussel oil product. GLX3 is CO₂-extracted specifically to preserve ETA alongside EPA and DHA, which is why it behaves differently from standard fish oil.

Q: What is ETA omega-3 and how is it different from EPA and DHA?

EPA, DHA, and ETA are all long-chain omega-3 fatty acids, but ETA has a structural difference that gives it a unique mechanism. Unlike EPA and DHA, ETA simultaneously blocks both the COX-2 and LOX inflammatory pathways — the two main routes through which your body produces inflammation. Most omega-3s only partially address one. ETA addresses both, which is why green-lipped mussel oil tends to outperform fish oil for joint-specific inflammation.

Q: What does ETA fatty acid actually do in the body?

ETA does something remarkable: it redirects the enzyme that normally produces arachidonic acid (ARA) — one of the primary drivers of inflammation — and converts it to EPA instead. So ETA doesn't just block inflammation; it intercepts the raw material your body would use to create it. It also acts as a dual COX/LOX inhibitor without disrupting the COX-1 pathway, which means it doesn't cause the gut and kidney side effects associated with NSAIDs.

Q: Can ETA omega-3 help with joint pain?

Yes — and this is where ETA stands out. Because it blocks both inflammatory pathways simultaneously (COX-2 and LOX), it addresses the full cycle of joint inflammation rather than just one arm of it. People taking GLX3 — which contains ETA alongside EPA and DHA — typically report noticing changes in joint comfort in the 6–12 week range with consistent daily use. Results vary by individual, and ETA works best as part of a sustained omega-3 protocol rather than a short-term fix.*

Q: How is ETA different from fish oil?

Standard fish oil contains EPA and DHA but no ETA. ETA is found almost exclusively in New Zealand green-lipped mussel (Perna canaliculus) — it's not present in salmon, sardine, or other fish oil sources. This is the core reason GLX3 produces different results than fish oil for joint health: the ETA content is unique to mussel oil, and it's preserved only through CO₂ extraction (heat-based processing destroys it).

Q: How long does ETA take to work?

Results vary depending on the individual, but most people taking GLX3 report noticing changes in joint comfort somewhere in the 6–12 week range with consistent daily use. As with any omega-3 supplement, building up in your system takes time, so consistency matters more than timing.*

*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.